Theun de Groot

Dr. Theun de Groot

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2022 in Emerging Microbes & Infections
Verified
Journal Article
Open access
BSBram Spruijtenburg
Bram Spruijtenburg
Hamid BadaliHamid Badali
Hamid Badali
MAMahdi Abastabar
Mahdi Abastabar
HMHossein Mirhendi
Hossein Mirhendi
SKSadegh Khodavaisy
Sadegh Khodavaisy
JMJacobus F. Meis
Jacobus F. Meis
Candida auris has emerged globally as a multidrug-resistant pathogen causing outbreaks in health care facilities. Whole genome sequencing (WGS) analysis has identified four major clades, while earlier WGS data from a single Iranian isolate suggested the existence of a potential fifth clade. Here, we confirm the existence of this fifth clade by providing WGS data of another four Iranian isolates. These clade V isolates differed less than 100 single-nucleotide polymorphisms (SNPs) between each other, while they were separated from the other clades by more than 200,000 SNPs. Two of these isolates were resistant to fluconazole and were found to harbour mutations in the TAC1b and ERG11 genes.

17 March 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
JAJoão N. de Almeida
João N. de Almeida
EFElaine Cristina Francisco
Elaine Cristina Francisco
FHFerry Hagen
Ferry Hagen
IBIgor B. Brandão
Igor B. Brandão
FPFelicidade Mota Pereira
Felicidade Mota Pereira
Arnaldo L. ColomboArnaldo L. Colombo
Arnaldo L. Colombo
In December 2020, Candida auris emerged in Brazil in the city of Salvador. The first two C. auris colonized patients were in the same COVID-19 intensive care unit. Antifungal susceptibility testing showed low minimal inhibitory concentrations of 1 µg/mL, 2 µg/mL, 0.03 µg/L, and 0.06 µg/mL for amphotericin B, fluconazole, voriconazole, and anidulafungin, respectively. Microsatellite typing revealed that the strains are clonal and belong to the South Asian clade C. auris. The travel restrictions during the COVID-19 pandemic and the absence of travel history among the colonized patients lead to the hypothesis that this species was introduced several months before the recognition of the first case and/or emerged locally in the coastline Salvador area.

26 January 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
AYAnamika Yadav
Anamika Yadav
ASAnubhav Singh
Anubhav Singh
YWYue Wang
Yue Wang
MHMerlijn van Haren
Merlijn van Haren
ASAshutosh Singht
Ashutosh Singht
ACAnuradha Chowdhary
Anuradha Chowdhary
Candida auris is a nosocomial pathogen responsible for an expanding global public health threat. This ascomycete yeast has been frequently isolated from hospital environments, representing a significant reservoir for transmission in healthcare settings. Here, we investigated the relationships among C. auris isolates from patients with chronic respiratory diseases admitted in a chest hospital and from their fomites, using whole-genome sequencing (WGS) and multilocus microsatellite genotyping. Overall, 37.5% (n = 12/32) patients developed colonisation by C. auris including 9.3% of the screened patients that were colonised at the time of admission and 75% remained colonised till discharge. Furthermore, 10% of fomite samples contained C. auris in rooms about 8.5 days after C. auris colonised patients were admitted. WGS and microsatellite typing revealed that multiple strains contaminated the fomites and colonised different body sites of patients. Notably, 37% of C. auris isolates were resistant to amphotericin B but with no amino acid substitution in ERG2, ERG3, ERG5, and ERG6 as compared to the reference strain B8441 in any of our strains. In addition, 55% of C. auris isolates likely had two copies of the MDR1 gene. Our results suggest significant genetic and ecological diversities of C. auris in healthcare setting. The WGS and microsatellite genotyping methods provided complementary results in genotype identification.

25 February 2020 in mBio
Verified
Journal Article
Open access
PDF file
TGTheun de Groot
Theun de Groot
YPYnze Puts
Ynze Puts
IBIndira Berrio
Indira Berrio
ACAnuradha Chowdhary
Anuradha Chowdhary
JMJacobus F. Meis
Jacobus F. Meis
Candida auris is an emerging fungal pathogen now recognized as a threat to public health. The pathogen has spread worldwide and causes mainly hospital-associated outbreaks. To track and trace outbreaks and to relate them to new introductions from elsewhere, whole-genome sequencing and amplified fragment length polymorphism (AFLP) have been used for molecular typing. Whole-genome sequencing is costly and available only at a few centers, and AFLP is a complicated technique and hard to interpret. We describe a novel simple STR genotyping technique based on short tandem repeats in the C. auris genome. We also show that the performance of this STR-based genotyping technique has proven comparable to that of WGS. Overall, this work provides a novel, rapid, reliable, and cost-effective method of molecular outbreak investigations of C. auris .

12 February 2019 in Mycoses
Verified
Journal Article
Open access
PDF file
TGTheun de Groot
Theun de Groot
ACAnuradha Chowdhary
Anuradha Chowdhary
JMJacobus F. Meis
Jacobus F. Meis
AVAndreas Voss
Andreas Voss
Summary: Background: Candida auris is a globally emerging yeast, causing severe infections in patients with underlying diseases. This yeast is responsible for several outbreaks within healthcare facilities, where it can be found on hospital surfaces and patient care devices. Spread from these fomites may be prevented by improving the decontamination of hospital surfaces. UV‐C decontamination may constitute an effective adjunct to routine room cleaning.Objectives: Our aim was to investigate the effect of different UV‐C exposure times and distance in killing C auris, using strains from different countries.Methods: Candida auris was seeded on glass slides and exposed to UV‐C for 5, 10, 20 and 30 minutes at 2 and 4 m.Results: A maximal effect of C auris killing was found after 30 minutes of UV‐C exposure at 2 m. With half the time or twice the distance, the efficacy strongly diminished to ~10 and ~50 fold, respectively. At suboptimal exposure times and distances, the C auris strains from Japan/Korea were more sensitive to UV‐C killing than C auris strains originating from Venezuela, Spain and India.Conclusions: Altogether, UV‐C exposure times and distance are the most critical parameters to kill C auris, while strain variations of C auris also determine UV‐C efficacy. Future studies should aim to determine the effect and place of UV‐C on surface decontamination in hospital setting.

15 September 2023 in Mycoses
Verified
Journal Article
Open access
BSBram Spruijtenburg
Bram Spruijtenburg
SASuhail Ahmad
Suhail Ahmad
Mohammad Assadullah AsadzadehMohammad Assadullah Asadzadeh
Mohammad Assadullah Asadzadeh
WAWadha Alfouzan
Wadha Alfouzan
IAInaam Al‐Obaid
Inaam Al‐Obaid
TGTheun de Groot
Theun de Groot
Candida auris is an emerging, multidrug‐resistant yeast, causing outbreaks in healthcare facilities. Echinocandins are the antifungal drugs of choice to treat candidiasis, as they cause few side effects and resistance is rarely found. Previously, immunocompromised patients from Kuwait with C. auris colonisation or infection were treated with echinocandins, and within days to months, resistance was reported in urine isolates. To determine whether the development of echinocandin resistance was due to independent introductions of resistant strains or resulted from intra‐patient resistance development, whole genome sequencing (WGS) single‐nucleotide polymorphism (SNP) analysis was performed on susceptible (n = 26) and echinocandin‐resistant (n = 6) isolates from seven patients. WGS SNP analysis identified three distinct clusters differing 17–127 SNPs from two patients, and the remaining isolates from five patients, respectively. Sequential isolates within patients had a maximum of 11 SNP differences over a time period of 1–10 months. The majority of isolates with reduced susceptibility displayed unique FKS1 substitutions including a novel FKS1M690V substitution, and nearly all were genetically related, ranging from only three to six SNP differences compared to susceptible isolates from the same patient. Resistant isolates from three patients shared the common FKS1S639F substitution; however, WGS analysis did not suggest a common source. These findings strongly indicate that echinocandin resistance is induced during antifungal treatment. Future studies should determine whether such echinocandin‐resistant strains are capable of long‐term colonisation, cause subsequent breakthrough candidiasis, have a propensity to cross‐infect other patients, or remain viable for longer time periods in the hospital environment.